Cargando…

Sarcopenia in daily practice: assessment and management

BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaudart, Charlotte, McCloskey, Eugène, Bruyère, Olivier, Cesari, Matteo, Rolland, Yves, Rizzoli, René, Araujo de Carvalho, Islène, Amuthavalli Thiyagarajan, Jotheeswaran, Bautmans, Ivan, Bertière, Marie-Claude, Brandi, Maria Luisa, Al-Daghri, Nasser M., Burlet, Nansa, Cavalier, Etienne, Cerreta, Francesca, Cherubini, Antonio, Fielding, Roger, Gielen, Evelien, Landi, Francesco, Petermans, Jean, Reginster, Jean-Yves, Visser, Marjolein, Kanis, John, Cooper, Cyrus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052976/
https://www.ncbi.nlm.nih.gov/pubmed/27716195
http://dx.doi.org/10.1186/s12877-016-0349-4
_version_ 1782458324617265152
author Beaudart, Charlotte
McCloskey, Eugène
Bruyère, Olivier
Cesari, Matteo
Rolland, Yves
Rizzoli, René
Araujo de Carvalho, Islène
Amuthavalli Thiyagarajan, Jotheeswaran
Bautmans, Ivan
Bertière, Marie-Claude
Brandi, Maria Luisa
Al-Daghri, Nasser M.
Burlet, Nansa
Cavalier, Etienne
Cerreta, Francesca
Cherubini, Antonio
Fielding, Roger
Gielen, Evelien
Landi, Francesco
Petermans, Jean
Reginster, Jean-Yves
Visser, Marjolein
Kanis, John
Cooper, Cyrus
author_facet Beaudart, Charlotte
McCloskey, Eugène
Bruyère, Olivier
Cesari, Matteo
Rolland, Yves
Rizzoli, René
Araujo de Carvalho, Islène
Amuthavalli Thiyagarajan, Jotheeswaran
Bautmans, Ivan
Bertière, Marie-Claude
Brandi, Maria Luisa
Al-Daghri, Nasser M.
Burlet, Nansa
Cavalier, Etienne
Cerreta, Francesca
Cherubini, Antonio
Fielding, Roger
Gielen, Evelien
Landi, Francesco
Petermans, Jean
Reginster, Jean-Yves
Visser, Marjolein
Kanis, John
Cooper, Cyrus
author_sort Beaudart, Charlotte
collection PubMed
description BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. METHODS: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. RESULTS: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. CONCLUSIONS: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.
format Online
Article
Text
id pubmed-5052976
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50529762016-10-06 Sarcopenia in daily practice: assessment and management Beaudart, Charlotte McCloskey, Eugène Bruyère, Olivier Cesari, Matteo Rolland, Yves Rizzoli, René Araujo de Carvalho, Islène Amuthavalli Thiyagarajan, Jotheeswaran Bautmans, Ivan Bertière, Marie-Claude Brandi, Maria Luisa Al-Daghri, Nasser M. Burlet, Nansa Cavalier, Etienne Cerreta, Francesca Cherubini, Antonio Fielding, Roger Gielen, Evelien Landi, Francesco Petermans, Jean Reginster, Jean-Yves Visser, Marjolein Kanis, John Cooper, Cyrus BMC Geriatr Debate BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. METHODS: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. RESULTS: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. CONCLUSIONS: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future. BioMed Central 2016-10-05 /pmc/articles/PMC5052976/ /pubmed/27716195 http://dx.doi.org/10.1186/s12877-016-0349-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Beaudart, Charlotte
McCloskey, Eugène
Bruyère, Olivier
Cesari, Matteo
Rolland, Yves
Rizzoli, René
Araujo de Carvalho, Islène
Amuthavalli Thiyagarajan, Jotheeswaran
Bautmans, Ivan
Bertière, Marie-Claude
Brandi, Maria Luisa
Al-Daghri, Nasser M.
Burlet, Nansa
Cavalier, Etienne
Cerreta, Francesca
Cherubini, Antonio
Fielding, Roger
Gielen, Evelien
Landi, Francesco
Petermans, Jean
Reginster, Jean-Yves
Visser, Marjolein
Kanis, John
Cooper, Cyrus
Sarcopenia in daily practice: assessment and management
title Sarcopenia in daily practice: assessment and management
title_full Sarcopenia in daily practice: assessment and management
title_fullStr Sarcopenia in daily practice: assessment and management
title_full_unstemmed Sarcopenia in daily practice: assessment and management
title_short Sarcopenia in daily practice: assessment and management
title_sort sarcopenia in daily practice: assessment and management
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052976/
https://www.ncbi.nlm.nih.gov/pubmed/27716195
http://dx.doi.org/10.1186/s12877-016-0349-4
work_keys_str_mv AT beaudartcharlotte sarcopeniaindailypracticeassessmentandmanagement
AT mccloskeyeugene sarcopeniaindailypracticeassessmentandmanagement
AT bruyereolivier sarcopeniaindailypracticeassessmentandmanagement
AT cesarimatteo sarcopeniaindailypracticeassessmentandmanagement
AT rollandyves sarcopeniaindailypracticeassessmentandmanagement
AT rizzolirene sarcopeniaindailypracticeassessmentandmanagement
AT araujodecarvalhoislene sarcopeniaindailypracticeassessmentandmanagement
AT amuthavallithiyagarajanjotheeswaran sarcopeniaindailypracticeassessmentandmanagement
AT bautmansivan sarcopeniaindailypracticeassessmentandmanagement
AT bertieremarieclaude sarcopeniaindailypracticeassessmentandmanagement
AT brandimarialuisa sarcopeniaindailypracticeassessmentandmanagement
AT aldaghrinasserm sarcopeniaindailypracticeassessmentandmanagement
AT burletnansa sarcopeniaindailypracticeassessmentandmanagement
AT cavalieretienne sarcopeniaindailypracticeassessmentandmanagement
AT cerretafrancesca sarcopeniaindailypracticeassessmentandmanagement
AT cherubiniantonio sarcopeniaindailypracticeassessmentandmanagement
AT fieldingroger sarcopeniaindailypracticeassessmentandmanagement
AT gielenevelien sarcopeniaindailypracticeassessmentandmanagement
AT landifrancesco sarcopeniaindailypracticeassessmentandmanagement
AT petermansjean sarcopeniaindailypracticeassessmentandmanagement
AT reginsterjeanyves sarcopeniaindailypracticeassessmentandmanagement
AT vissermarjolein sarcopeniaindailypracticeassessmentandmanagement
AT kanisjohn sarcopeniaindailypracticeassessmentandmanagement
AT coopercyrus sarcopeniaindailypracticeassessmentandmanagement